Production (Stage)
Elanco Animal Health Incorporated
ELAN
$13.81
-$0.36-2.54%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 128.65% | 127.46% | 117.92% | -1,010.62% | -4,907.69% |
| Total Depreciation and Amortization | -2.53% | -2.81% | -1.76% | -0.32% | 3.09% |
| Total Amortization of Deferred Charges | -25.93% | -25.93% | -16.92% | -16.92% | -16.92% |
| Total Other Non-Cash Items | -154.53% | -154.87% | -153.67% | 1,056.70% | 275.79% |
| Change in Net Operating Assets | 334.21% | 149.67% | 145.70% | 103.27% | 93.32% |
| Cash from Operations | 27.99% | 99.63% | 310.24% | 372.03% | 13.28% |
| Capital Expenditure | -34.29% | -5.00% | 19.89% | 26.26% | 20.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1,100.00% | -89.47% | 100.00% | 81.25% | 81.25% |
| Divestitures | 1,874.24% | -- | -- | -- | -- |
| Other Investing Activities | -- | -90.00% | 60.00% | 112.50% | 100.00% |
| Cash from Investing | 1,480.52% | 785.21% | 677.62% | 68.25% | 62.44% |
| Total Debt Issued | 44.00% | -5.00% | -5.00% | 128.00% | -55.56% |
| Total Debt Repaid | -173.67% | -202.07% | -244.46% | -257.93% | 39.39% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -76.92% | -183.33% | -360.00% | 15.79% | 53.57% |
| Cash from Financing | -397.54% | -1,697.59% | -5,610.71% | -940.00% | -62.29% |
| Foreign Exchange rate Adjustments | -43.33% | -658.33% | -170.00% | -257.14% | -130.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 425.93% | 1,557.14% | 232.97% | 135.00% | 212.50% |